Publication | Year | ||||||||
---|---|---|---|---|---|---|---|---|---|
Patient centered care: A multidisciplinary and holistic approach Authors : Giovambattista Desideri , Nicola Montano , Giorgio SestiJournal : European Journal of Internal Medicine Journal Reference count : 22 Volume : 122 Pages : 119-120 |
2024 | ||||||||
Clinical implications of the biological ambivalence of uric acid Authors : Giovambattista Desideri , Giorgio SestiJournal : European Journal of Internal Medicine Journal Reference count : 15 Volume : 112 Pages : 24-26 |
2023 | ||||||||
Effetti pleiotropici della metformina: hanno rilevanza clinica? Authors : Giorgio SestiJournal : Il Diabete Volume : 34 |
2022 | ||||||||
Bempedoic Acid: A New Tool for LDL-Cholesterol Control in Patients with Coronary Artery Disease Authors : Claudio Bilato , Giorgio Sesti , Maurizio AvernaJournal : Reviews in Cardiovascular Medicine Journal Reference count : 27 Volume : 23 |
2022 | ||||||||
The contribution of unrecognized factors to the diabetes epidemic Authors : Michael Bergman , Ram Jagannathan , Giorgio SestiJournal : Diabetes/Metabolism Research and Reviews Journal Reference count : 25 Volume : 36 |
2020 | ||||||||
Authors :
Teresa Vanessa Fiorentino
, Giorgio Sesti
Journal : il Diabete Volume : 32 |
2020 | ||||||||
Authors :
Matteo Monami
, Giorgio Sesti
, Edoardo Mannucci
Journal : Diabetes, Obesity and Metabolism Journal Reference count : 32 Volume : 21 Pages : 903-908 |
2018 | ||||||||
Authors :
Paola Fioretto
, Andrea Giaccari
, Giorgio Sesti
Journal : Cardiovascular Diabetology Journal Reference count : 81 Volume : 14 |
2015 | ||||||||
Authors :
Teresa Vanessa Fiorentino
, Giorgio Sesti
Journal : Endocrine Journal Reference count : 48 Volume : 53 Pages : 373-380 |
2015 | ||||||||
Role of C Reactive Protein (CRP) in Leptin Resistance Authors : Marta Hribal , Teresa Fiorentino , Giorgio SestiJournal : Current Pharmaceutical Design Volume : 20 Pages : 609-615 |
2014 | ||||||||
Individualized Therapy for Type 2 Diabetes Authors : Gaia Chiara Mannino , Giorgio SestiJournal : Molecular Diagnosis & Therapy Journal Reference count : 276 Volume : 16 Pages : 285-302 |
2012 | ||||||||
Glycemic Control Impact on Body Weight Potential to Reduce Cardiovascular Risk Authors : Giorgio SestiJournal : Diabetes Care Journal Reference count : 25 Volume : 34 Pages : S272-S275 |
2011 | ||||||||
Authors :
Marta Letizia Hribal
, Giorgio Sesti
Journal : Clinical Investigation Journal Reference count : 64 Volume : 1 Pages : 327-343 |
2011 | ||||||||
Liraglutide, the once-daily human GLP-1 analog, in the treatment of Type 2 diabetes Authors : Marta Letizia Hribal , Giorgio SestiJournal : Expert Review of Endocrinology & Metabolism Journal Reference count : 59 Volume : 5 Pages : 495-505 |
2010 | ||||||||
Authors :
Eduard Montanya
, Giorgio Sesti
Journal : Clinical Therapeutics Journal Reference count : 81 Volume : 31 Pages : 2472-2488 |
2009 | ||||||||
Pathophysiology of insulin resistance Authors : Giorgio SestiJournal : Best Practice & Research Clinical Endocrinology & Metabolism Journal Reference count : 99 Volume : 20 Pages : 665-679 |
2006 | ||||||||
Role of the Insulin Receptor Variant Forms in Human Metabolic Disorders Authors : Giorgio SestiJournal : Current Genomics Volume : 4 Pages : 295-307 |
2003 | ||||||||
Apoptosis in the beta cells: cause or consequence of insulin secretion defect in diabetes? Authors : Giorgio SestiJournal : Annals of Medicine Journal Reference count : 62 Volume : 34 Pages : 444-450 |
2002 | ||||||||
Insulin receptor substrate polymorphisms and Type 2 diabetes mellitus Authors : Giorgio SestiJournal : Pharmacogenomics Volume : 1 Pages : 343-357 |
2000 | ||||||||
Genotyping:Insulin receptor variant forms and Type 2 diabetes mellitus Authors : Giorgio SestiJournal : Pharmacogenomics Volume : 1 Pages : 49-61 |
2000 |